Back to News
Jan 13, 2026 12:00 PM

Court Orders Recalculation Of Damages In Johnson & Johnson Auris Case

Johnson & Johnson (NYSE:JNJ) on Monday reportedly secured a partial legal victory after Delaware's highest court overturned a portion of a $1 billion damages award tied to its acquisition of surgical robotics company Auris Health.

In a unanimous ruling issued Monday, Reuters reported that the Delaware Supreme Court set aside part of a September 2024 judgment that had favored former Auris shareholders.

In 2019, Johnson & Johnson acquired Auris Health for approximately $3.4 billion in cash. Additional contingent payments of up to $2.35 billion, in the aggregate, may be payable upon reaching certain predetermined milestones.

What Happened

The lawsuit filed in 2024 claimed that Johnson & Johnson was struggling to develop its own surgical robot, Verb, despite significant investment.

With Verb behind schedule and surgical robotics strategically critical, Johnson & Johnson viewed Auris as a solution.

Auris agreed after securing Johnson & Johnson's commitment to apply commercially reasonable efforts consistent with a "priority medical device."

Following the acquisition, Johnson & ...